ValuEngine Downgrades Kewaunee Scientific (KEQU) to Hold

ValuEngine lowered shares of Kewaunee Scientific (NASDAQ:KEQU) from a buy rating to a hold rating in a research report released on Tuesday.

Shares of KEQU opened at $27.73 on Tuesday. The stock has a market cap of $75.20 million, a PE ratio of 11.67 and a beta of 0.03. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.23 and a quick ratio of 1.71. Kewaunee Scientific has a 52 week low of $25.15 and a 52 week high of $38.80.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings data on Tuesday, August 28th. The technology company reported $0.50 EPS for the quarter, missing the Zacks’ consensus estimate of $0.51 by ($0.01). The company had revenue of $42.15 million for the quarter. Kewaunee Scientific had a net margin of 3.28% and a return on equity of 14.01%.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 17th. Stockholders of record on Tuesday, December 4th will be given a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 2.74%. The ex-dividend date of this dividend is Monday, December 3rd.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Dimensional Fund Advisors LP raised its position in shares of Kewaunee Scientific by 1.3% during the third quarter. Dimensional Fund Advisors LP now owns 211,859 shares of the technology company’s stock valued at $6,674,000 after buying an additional 2,639 shares during the last quarter. Renaissance Technologies LLC raised its position in shares of Kewaunee Scientific by 3.7% during the third quarter. Renaissance Technologies LLC now owns 97,700 shares of the technology company’s stock valued at $3,078,000 after buying an additional 3,500 shares during the last quarter. North Star Investment Management Corp. raised its position in shares of Kewaunee Scientific by 2.4% during the third quarter. North Star Investment Management Corp. now owns 84,629 shares of the technology company’s stock valued at $2,666,000 after buying an additional 2,004 shares during the last quarter. BlackRock Inc. raised its position in shares of Kewaunee Scientific by 125.3% during the third quarter. BlackRock Inc. now owns 28,088 shares of the technology company’s stock valued at $885,000 after buying an additional 15,620 shares during the last quarter. Finally, FMR LLC raised its position in shares of Kewaunee Scientific by 120.6% during the third quarter. FMR LLC now owns 24,597 shares of the technology company’s stock valued at $775,000 after buying an additional 13,447 shares during the last quarter. 50.28% of the stock is owned by institutional investors and hedge funds.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture products. The company operates in two segments, Domestic and International. Its products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.

Featured Article: Market Capitalization, Large-Caps, Mid-Caps, Small-Caps

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply